Article Text

Download PDFPDF
Concise report
Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to other patient-reported outcomes in a register of patients with rheumatoid arthritis
  1. Turid Heiberg1,2,
  2. Cathrine Austad3,
  3. Tore K Kvien3,
  4. Till Uhlig3
  1. 1Department for Research and Education, Oslo University Hospital, Ulleval, Oslo, Norway
  2. 2Lovisenberg Diaconal College, Oslo, Norway
  3. 3Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
  1. Correspondence to Turid Heiberg, Department for Research and Education, Oslo University Hospital, Ulleval, N-0407 Oslo, Norway; turid.heiberg{at}medisin.uio.no

Abstract

Objective Delegates at the Outcome Measures in Rheumatology (OMERACT) 10 conference (Borneo, 4–8 May 2010) questioned how the new seven-domain Rheumatoid Arthritis Impact of Disease (RAID) score performs as a global measure. Score distributions and associations between the RAID score and patient-reported outcomes (PROs) and demographic variables were examined in a large sample of rheumatoid arthritis (RA) patients.

Methods 1086 patients in the Oslo RA Register responded to a postal survey with commonly used PROs. Bivariate associations between the RAID score and other measures are reported as Pearson correlation coefficients.

Results The mean RAID was 3.37±2.17. The distribution of the RAID score showed a slight floor effect: 17.5% had a score between 0 and 1, and 14.4% between 1 and 2, whereas only 1.0% and 0.3% had scores between 8 and 9, and 9 and 10, respectively. Correlations between the RAID score and the patient global assessment, Rheumatoid Arthritis Disease Activity Index, Short-Form (SF)-6D and EQ-5D were 0.82, 0.82, −0.77 and −0.73, respectively. Strong correlation was also seen between RAID and pain, the domain with highest weight, whereas correlations to measures of other RAID domains were moderate. The RAID score was higher in women than men (3.49 vs 2.95, p=0.001).

Conclusion The RAID score was correlated more strongly to other global measures than to PROs, reflecting single health domains.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Patient consent Obtained.

  • Ethics approval This study was conducted with the approval of the South-Eastern Regional Committee for Research Ethics in Medicine and Health.

  • Competing interests Professor Johannes Bijlsma was the handling Editor

  • Provenance and peer review Not commissioned; externally peer reviewed.